Article

Zinc blend available

OCuSOFT Inc.'s proprietary blend of zinc and phytase (Zytaze) is now available for physician dispensing. This proprietary medical food is designed to provide nutritional support to enhance the effectiveness of botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, or cosmetic procedures.

Richmond, TX-OCuSOFTInc.’s proprietary blend of zinc and phytase (Zytaze) is now available for physician dispensing.

This medical food is designed to provide nutritional support to enhance the effectiveness of botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, or cosmetic procedures.

The blend is one of organic zinc and phytase, an enzyme that aids zinc absorption and increases bioavailability. According to OCuSOFT, increasing zinc bioavailability is important because, to be effective, each botulinum toxin molecule must be associated with a zinc molecule, yet many patients’ diets are zinc-deficient.

Taking the zinc and phytase blend each day for 4 days before and on the day of an injection may increase both the effect of treatments and the duration of botulinum toxin, and could mean using less toxin, financial savings, increased safety, and more consistent botulinum toxin results for many patients, according to OCuSOFT.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.